Ongoing intracerebral bleeding despite hemostatic treatment associated with a spot sign in a patient on oral anticoagulation therapy.
Rizos
T
T
Department of Neurology, University of Heidelberg, Im Neuenheimer Feld 400, Heidelberg, Germany. Timolaos.Rizos@med.uni-heidelberg.de
Rohde
S
S
Dorner
N
N
Steiner
T
T
D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D002533:Cerebral Angiography; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000175:diagnosis* / Q000517:prevention & control*; D017809:Fatal Outcome; D005260:Female; D006406:Hematoma / Q000139:chemically induced / Q000175:diagnosis* / Q000517:prevention & control*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D011379:Prognosis; D016896:Treatment Outcome
D000925:Anticoagulants; D006490:Hemostatics